Sox9 directs divergent epigenomic states in brain tumor subtypes10.1073/pnas.2202015119

• Published in: Proceedings of the National Academy of Sciences - PNAS Vol. 119; no. 29; p. 1
• Main Authors: Sardar, Debosmita, Chen, Hsiao-Chi, Reyes, Amanda, Varadharajan, Srinidhi, Jain, Antrix, Mohila, Carrie, Curry, Rachel, Lozzi, Brittney, Rajendran, Kavitha, Cervantes, Alexis, Yu, Kwanha, Jalali, Ali, Rao, Ganesh, Mack, Stephen C, Deneen, Benjamin
• Format: Journal Article
• Language: English
• Published: Washington National Academy of Sciences 19-07-2022
• Subjects: Animal models; Brain; Brain cancer; Brain tumors; Epigenetics; Gene expression; Glioma; Histones; Molecular modelling; Protein interaction; RelA protein; Sox9 protein; Tumorigenesis; Tumors
• ISSN: 0027-8424; 1091-6490
• DOI: 10.1073/pnas.2202015119

Epigenetic dysregulation is a universal feature of cancer that results in altered patterns of gene expression that drive malignancy. Brain tumors exhibit subtype-specific epigenetic alterations; however, the molecular mechanisms responsible for these diverse epigenetic states remain unclear. Here, we show that the developmental transcription factor Sox9 differentially regulates epigenomic states in high-grade glioma (HGG) and ependymoma (EPN). Using our autochthonous mouse models, we found that Sox9 suppresses HGG growth and expands associated H3K27ac states, while promoting ZFTA-RELA (ZRFUS) EPN growth and diminishing H3K27ac states. These contrasting roles for Sox9 correspond with protein interactions with histone deacetylating complexes in HGG and an association with the ZRFUS oncofusion in EPN. Mechanistic studies revealed extensive Sox9 and ZRFUS promoter co-occupancy, indicating functional synergy in promoting EPN tumorigenesis. Together, our studies demonstrate how epigenomic states are differentially regulated in distinct subtypes of brain tumors, while revealing divergent roles for Sox9 in HGG and EPN tumorigenesis.